Medicare subsidies may help more women stick with breast cancer drugs

By Lisa Rapaport (Reuters Health) – Women on Medicare who get subsidies to help defray the cost of drugs may be less likely to stop taking hormone therapy for breast cancer than those who don’t get financial assistance, a U.S. study suggests. Overall, 27 percent of these women received subsidies through a Medicare program for low-income patients that eliminates or substantially reduces out-of-pocket costs for premiums, co-payments, deductibles and medications. “We found that women with the subsidy (which also means they have fewer financial resources) are more likely to take their medications and continue treatment,” said lead study author Dr. Alana Biggers of the University of Illinois- Chicago College of Medicine.

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us